Outsourcing

Jul 12, 2016
By BioPharm International Editors
EAG Laboratories announces new company identity and intent to expand testing, analysis, and characterization capabilities across multiple markets.
Jul 11, 2016
By BioPharm International Editors
Patheon launches initial public offering to repay outstanding notes and expenses.
Jul 02, 2016
BioPharm International
CDMOs need to be aware that unfavorable public markets put emerging bio/pharma R&D spending at risk in 2017.
Jul 01, 2016
BioPharm International
Capacity for complex therapeutics is becoming increasingly difficult to predict.
Jun 15, 2016
BioPharm International eBooks
By BioPharm International Editors
Biopharmaceutical contractors continue to invest in development, facility upgrades, technological advancement, and mergers and acquisitions.
Jun 15, 2016
BioPharm International eBooks
Adopting best practices and collaborating more closely with contract research organizations can help drugs get past Phase III.
Jun 15, 2016
BioPharm International eBooks
Biopharmaceutical manufacturers continue to put quality at the forefront of their relationships.
Jun 15, 2016
BioPharm International eBooks
New drug approval policies promote industry growth and injectable contract manufacturing opportunities in China.
Jun 15, 2016
BioPharm International eBooks
For successful drug delivery partnerships, it’s important to take a long-term view, focus on simple designs, and address potential payer concerns up front.
Jun 15, 2016
BioPharm International eBooks
Planning ahead is key to enabling a continuous and secure supply chain that adapts to changes in market demand.
lorem ipsum